A Phase II Study of Sequential Capecitabine Plus Oxaliplatin Followed by Docetaxel Plus Capecitabine in Patients With Unresectable Gastric Adenocarcinoma: The TCOG 3211 Clinical Trial

Fluorouracil and platinum are considered the standard treatment options for advanced gastric cancer. Docetaxel is also an effective agent and it shows no cross-resistance with fluorouracil and platinum. The combination treatment of docetaxel with fluorouracil and platinum has been explored, but it d...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Medicine (Baltimore)
Main Authors: Chen, Ming-Huang, Lin, Johnson, Hsiao, Chin-Fu, Shan, Yan-Shen, Chen, Yeu-Chin, Chen, Li-Tzong, Liu, Tsang-Wu, Li, Chung-Pin, Chao, Yee
Format: Artigo
Jezik:Inglês
Izdano: Wolters Kluwer Health 2016
Teme:
5700
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4998286/
https://ncbi.nlm.nih.gov/pubmed/26817912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000002565
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki